Literature DB >> 22518035

Thoracolaparoscopy oesophagectomy and extensive two-field lymphadenectomy for oesophageal cancer: introduction and teaching of a new technique in a high-volume centre.

Jiangbo Lin1, Mingqiang Kang, Chun Chen, Ruobai Lin, Wei Zheng, Yong Zhug, Fan Deng, Shuchen Chen.   

Abstract

OBJECTIVES: The aim of this study was to assess the experience of a high-volume centre with thoracolaparoscopy radical oesophagectomy and to evaluate the feasibility, tumour clearance, the learning curve and reproducibility of this technique.
METHODS: Eighty patients with thoracic oesophageal cancer who underwent thoracolaparoscopic oesophagectomy (TLE) were enrolled in this study. Two attending surgeons (Mingqiang Kang and Ruobai Lin) independently performed the procedure as operating surgeons. The 60 patients who had surgery performed on them by the senior attending surgeon, Mingqiang Kang, were divided into three groups of 20 patients: groups A, B and C. The results from the three groups were compared in order to detect any changes in the success of TLE as a way of monitoring the development of the surgeon's technical skill. Another 20 patients had surgery performed on them by the new attending surgeon, Ruobai Lin, and were classified into the fourth group, D. The results from Group D were compared with those of the other three groups to evaluate the reproducibility of our technique.
RESULTS: There was no significant difference between the four groups with respect to age, gender, location of tumour or staging. The duration of both the thoracoscopic and laparoscopic procedures was significantly longer in Group A. The amount of estimated blood loss was significantly more in Group A than in the other groups. The number of lymph nodes dissected was similar in Groups A and D, whereas that of retrieved nodes was larger in Groups B and C. There was no significant difference in the incidence of respiratory complications, recurrent nerve palsy, anastomotic leaks, arrhythmia, chylothorax and delayed gastric emptying among the four groups.
CONCLUSIONS: When TLE procedures are started in units with a large volume of oesophageal resections, and when there is support from colleagues within the unit, transition from open to TLE can be achieved safely, with a satisfactory oncological outcome. A plateau of TLE skill was reached after 40 cases had been performed. If mini-fellowship training with supervision from senior surgeons is used, it is possible for a new attending surgeon to attain the requisite basic skill to perform TLE in a relatively short period of time.

Entities:  

Mesh:

Year:  2012        PMID: 22518035     DOI: 10.1093/ejcts/ezs151

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  Thoracoscopic oesophageal mobilization during thoracolaparoscopy three-stage oesophagectomy: a comparison of lateral decubitus versus semiprone positions.

Authors:  Jiangbo Lin; Mingqiang Kang; Chun Chen; Ruobai Lin
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-09

Review 2.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Short-term outcomes and one surgeon's learning curve for thoracoscopic esophagectomy performed with the patient in the prone position.

Authors:  Taro Oshikiri; Takashi Yasuda; Hiroshi Hasegawa; Masashi Yamamoto; Shingo Kanaji; Kimihiro Yamashita; Takeru Matsuda; Yasuo Sumi; Tetsu Nakamura; Yasuhiro Fujino; Masahiro Tominaga; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Surg Today       Date:  2016-07-11       Impact factor: 2.549

4.  Trainee competence in thoracoscopic esophagectomy in the prone position: evaluation using cumulative sum techniques.

Authors:  Taro Oshikiri; Takashi Yasuda; Masashi Yamamoto; Shingo Kanaji; Kimihiro Yamashita; Takeru Matsuda; Yasuo Sumi; Tetsu Nakamura; Yasuhiro Fujino; Masahiro Tominaga; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Langenbecks Arch Surg       Date:  2016-07-29       Impact factor: 3.445

5.  The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma.

Authors:  Ming-Qiu Chen; Cheng Chen; Hai-Jie Lu; Ben-Hua Xu
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

6.  Three-dimensional vs two-dimensional video assisted thoracoscopic esophagectomy for patients with esophageal cancer.

Authors:  Zhao Li; Jing-Pei Li; Xiong Qin; Bin-Bin Xu; Yu-Dong Han; Si-Da Liu; Wen-Zhuo Zhu; Ming-Zheng Peng; Qiang Lin
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

7.  Updated experiences with minimally invasive McKeown esophagectomy for esophageal cancer.

Authors:  Ju-Wei Mu; Shu-Geng Gao; Qi Xue; You-Sheng Mao; Da-Li Wang; Jun Zhao; Yu-Shun Gao; Jin-Feng Huang; Jie He
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

8.  Comparison of perioperative outcomes between open and minimally invasive esophagectomy for esophageal cancer.

Authors:  Teng Mao; Wentao Fang; Zhitao Gu; Xufeng Guo; Chunyu Ji; Wenhu Chen
Journal:  Thorac Cancer       Date:  2015-04-24       Impact factor: 3.500

9.  Learning Curve for Lymph Node Dissection Around the Recurrent Laryngeal Nerve in McKeown Minimally Invasive Esophagectomy.

Authors:  Zi-Yi Zhu; Rao-Jun Luo; Zheng-Fu He; Yong Xu; Shao-Hua Xu; Qiang Zhang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

10.  Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview.

Authors:  Chengchu Zhu; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.